Ardelyx Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.93

+0.05 (+1.74%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +1,508.9% upside

Low Target $33.22

Average Target $47.14

High Target $55.45

Current Price $2.93

Current
$2.93

Target
$47.14

$33.22 $47.14 avg $55.45

Scenario Analysis

Bear Case

$33.22

1,033.8%

Low target

Base Case

$47.14

+1,508.9%

Avg target

Bull Case

$55.45

+1,792.5%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$8.40

-65.1% from high

52-Week Low

$2.96

+-0.8% from low

Target vs 52W High

$47.14

+461.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.4%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.8%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+113.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-20.3%
MRNA Moderna Inc	Hold	31	32%	$149.45	-42.1%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.6%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-54.5%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-40.3%